Principal Investigator
Jonathan Schatz
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20221326
Clinical Trial Summary
A phase I study with an expansion cohort of duvelisib and nivolumab in mycosis fungoides (MF) and Szary syndrome (SS)
Phase
Phase I
Funding Agency/Sponsor
National Cooperative Group
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2437261